HealthCap

HealthCap is a venture capital firm founded in 1996 and based in Stockholm, Sweden, specializing in investments within the life sciences sector. With over €800 million in committed capital, it is one of the largest providers of venture capital in Europe focused on healthcare and biotechnology. The firm targets both early and late-stage investments, seeking transformative therapies and innovative technologies that address high unmet medical needs. HealthCap invests globally, primarily in pharmaceuticals, biotechnology, and related fields, and aims to act as a lead investor, often acquiring minority stakes and seeking board representation in its portfolio companies. Since its inception, HealthCap has managed multiple funds and has completed numerous investments, demonstrating its commitment to advancing medical practices and improving patient outcomes.

Johan Christenson Ph.D

Partner

Kristina Ekberg

Partner & General Counsel

Anki Forsberg

Partner & Chairwoman

Peder Fredrikson

Co-Founder & Partner

Jonas Hansson

Partner

Carl Kilander

Partner

Staffan Lindstrand

Partner

Max Odlander

Partner

Björn Odlander

Managing Partner

Per Samuelsson

Partner

Mårten Steen

Managing Partner

Eugen Steiner

Venture Partner

Alex Valcu

Partner

Past deals in Copenhagen

Hemab

Series A in 2021
Hemab is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders.

ADCendo

Series A in 2021
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.